White Paper
Nutrition as the keystone for obesity management medication
The consumer health market opportunity behind the rise of obesity
Oct 15, 2025

Are you prepared to address the nutritional implications of GLP-1 therapies and their impact on obesity management?

IQVIA Consumer Health’s latest whitepaper provides the insights you need to understand why nutrition is central to patient outcomes and market growth in this new era of obesity care.

Developed by IQVIA Consumer Health experts, it explores:

  • How GLP-1 receptor agonists change nutrient intake, absorption, and long-term health outcomes.
  • The clinical impact of nutrient deficiencies, lean mass loss, and reduced quality of life in GLP-1 RA users.
  • Evidence-based nutritional strategies to optimize results and safeguard patient health.
  • The critical role - and opportunity - for the medical nutrition industry in shaping the future of obesity treatment.

Complete the form on this page to download the whitepaper and understand why nutrition is the keystone of obesity management in the GLP-1 era.

Explore our resources on nutrition’s role in GLP-1 therapy

Nutrition As The Keystone to Success During GLP-1 Treatment – Webinar

Watch our on-demand webinar to discover how nutrition supports long-term success with GLP-1 therapies, driving better outcomes, adherence, and sustainable obesity management.

Nutrition As The Keystone to Success During GLP-1 Treatment – Slides

Review the slides from our expert discussion covering the changing landscape of obesity care, nutrient shortfalls in GLP-1 users, the first 90 days of therapy, and opportunities for innovation across the health and nutrition ecosystem.

Ready to take the next step?
Whether you’re exploring opportunities in GLP-1 therapies, clinical nutrition or broader obesity-care innovation, get in touch and tell us how we can help.

Related solutions

Contact Us